Sort
64,565 grants matching “drug discovery”
Targeting Mutant KRAS for Cancer Therapy
$924,613Said M Sebti · H. Lee Moffitt Cancer Ctr & Res Inst · R35 · FY2018 · CA
CATALYTIC METHODS FOR ORGANIC SYNTHESIS
$924,219Stephen L Buchwald · Massachusetts Institute Of Technology · R37 · FY2009 · GM
Drug candidates that disrupt the NEMO/IKK signaling complex for the treatment of
$924,148Stig K. Hansen · Carmot Therapeutics, Inc. · R44 · FY2014 · CA
A Comprehensive Platform for Transporter Mediated Drug-Drug Interaction Studies
$924,118Yong Huang · Optivia Biotechnology, Inc. · R44 · FY2011 · GM
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$924,001Joseph M Fox · University Of Delaware · P20 · FY2024 · GM
Cancer Gene Discovery to Identify Targetable Targets
$924,000Carlo M Croce · Ohio State University · R35 · FY2020 · CA
Cancer Gene Discovery to Identify Targetable Targets
$924,000Carlo M Croce · Ohio State University · R35 · FY2017 · CA
Cancer Gene Discovery to Identify Targetable Targets
$924,000Carlo M Croce · Ohio State University · R35 · FY2016 · CA
Cancer Gene Discovery to Identify Targetable Targets
$924,000Carlo M Croce · Ohio State University · R35 · FY2018 · CA
Cancer Gene Discovery to Identify Targetable Targets
$924,000Carlo M Croce · Ohio State University · R35 · FY2015 · CA
Mechanisms of DNA Homology-directed Genome Repair and Tumor Suppression
$924,000Patrick Sung · University Of Texas Hlth Science Center · R35 · FY2020 · CA
Signal Transduction Events and the Regulation of Cell Growth
$923,994Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2019 · CA
PREVENTABLE Biorepository and Laboratory
$923,660Laura Kristin Newby · Duke University · U19 · FY2019 · AG
Development of the first label-free and high-throughput, cell-based assay that reports on specific enzyme activities
$923,599Zachary Gurard-Levin · Samdi Tech, Inc. · R44 · FY2021 · CA
GenePattern and GenePattern Notebook: Integrative 'Omic Analysis for Cancer Research
$923,435Jill P. Mesirov · University Of California, San Diego · U24 · FY2021 · CA
Towards a quantitative understanding of tumor evolution
$923,400Raul Rabadan · Columbia University Health Sciences · R35 · FY2024 · CA
Genes contributing for nicotine dependence in humans
$923,267Kari Stefansson · Decode Genetics, Ehf · R01 · FY2015 · DA
A Comprehensive Platform for Transporter Mediated Drug-Drug Interaction Studies
$923,185Yong Huang · Optivia Biotechnology, Inc. · R44 · FY2012 · GM
Pediatric Oncology Clinical Research Training Program
$923,163Susan M Blaney · Baylor College Of Medicine · K12 · FY2020 · CA
High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNA
$923,143Ross S Chambers · Integral Molecular · R44 · FY2025 · GM
Genetic Studies of Alzheimer Disease in Koreans
$923,007Lindsay A. Farrer · Boston University Medical Campus · U01 · FY2023 · AG
Molecular Biology of Pediatric Tumors
$922,783Lee J. Helman · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Identifying Genetic Variants Associated with Opioid Overdose Mortality
$922,672Elliot C Nelson · Washington University · R01 · FY2022 · DA
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
$922,470Sanford D Markowitz · Case Western Reserve University · R35 · FY2019 · CA
Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery
$922,420Xu Han · Cryocrate, Llc · R44 · FY2025 · OD